Medium-Term Management Plan and Three Key Strategies for the Fiscal Year Ending March 2030

「In May 2026, the Group announced a medium-term management plan aimed at sustained medium- to long-term growth in performance. Under the plan, through the fiscal year ending March 2030, the Group has positioned stable growth in the domestic cell banking market and development of the Southeast Asian market originating from Singapore as the two pillars of its growth strategy and is pursuing medium- to long-term business expansion. To achieve the plan, the Group will pursue 3 priority strategies: strengthening the domestic business platform, promoting overseas expansion, and expanding clinical applications and utilization.」